Respreeza

Product
Active substances: human alpha1-proteinase inhibitor. Therapeutic area: Genetic Diseases, Inborn;Lung Diseases. ATC code: B02AB02
Reason
Quality defect
Classification
Class I
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2026-11-04
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/9f3ad07b-4aa6-4ed1-b0ff-25590a53085f